611
SSGJ-611-AD-III-01
Phase 3 small_molecule active
Quick answer
611 for Dermatitis, Atopic is a Phase 3 program (small_molecule) at Sunshine Biopharma with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Dermatitis, Atopic
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active